Transplacental reversal of meperidine depression in the fetus by naloxone.
D000498:Allyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D001034:Apgar Score; D001835:Body Weight; D036861:Delivery, Obstetric; D004988:Ethers, Cyclic / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008423:Maternal Age; D008431:Maternal-Fetal Exchange; D008614:Meperidine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D009019:Morphinans / Q000494:pharmacology*; D011247:Pregnancy; D013997:Time Factors
D000498:Allyl Compounds; D004988:Ethers, Cyclic; D009019:Morphinans; D008614:Meperidine